Potentials of phenolic molecules of natural origin and their derivatives as anti-HIV agents.
Identification of phenolic compounds and their derivatives interfering the several steps of the viral life cycle of the human immunodeficiency virus type 1 (HIV-1) is focused for the development of novel molecules for the treatment of AIDS. Several phenolic compounds isolated and characterized from natural sources have been studied in detail and found to exhibit inhibitory effects against different steps of the HIV-1 life cycle, including virus-cell fusion and virus absorption, reverse transcription, integration (IN) and proteolytic cleavage. In the review, we are summarizing some strong evidences demonstrating several phenolic molecules and their derivatives from natural sources display promising anti-HIV-1 activities. The anti-HIV compounds have been organized in this review according to their mechanism of action in the life cycle of HIV. We also mentioned some findings using in silico approaches, like virtual screening, docking, neural network, etc., and even the chemogenomics and/or functional genomics approaches could be useful for the quick identifying promising new lead anti-HIV molecules without having any other unwanted pharmacological effects. Plants having large amount of phenolic compounds, can be considered as strong sources of molecules for the treatment of HIV-1. Despite the continuous advances made in antiretroviral combination therapy, AIDS has become the leading cause of death in Africa and the fourth worldwide. Today, many research groups are exploring the bio- and chemo-diversity of the plant kingdom to find new and better anti-HIV drugs with novel mechanisms of action.
Hassan Khan
Mahmud Tareq
MT
Pharmacology Research Laboratory, Faculty of Pharmaceutical Sciences, University of Science and Technology Chittagong, Chittagong, Bangladesh. mahmud.khan@fagmed.uit.no
Ather
Arjumand
A
D019380:Anti-HIV Agents / Q000737:chemistry / Q000378:metabolism* / Q000627:therapeutic use*; D001688:Biological Products / Q000737:chemistry / Q000378:metabolism* / Q000627:therapeutic use*; D004339:Drug Compounding / Q000639:trends*; D010636:Phenols / Q000737:chemistry / Q000378:metabolism* / Q000627:therapeutic use*
D019380:Anti-HIV Agents; D001688:Biological Products; D010636:Phenols